BBP Holdings
67 holdings in the fund's latest file; the data source updated it on Oct 8, 2026.
The fund reports 198 holdings; the file lists 67.
Top 25 Holdings
| # | Holding | Weight | Shares (as reported) | Value (as reported) |
|---|---|---|---|---|
| 1 | Moderna Inc | 5.21% | 33,770 | $6.6M |
| 2 | Iovance Biotherapeutics Inc | 4.19% | 413,111 | $5.3M |
| 3 | Omeros Corp | 2.84% | 192,959 | $3.6M |
| 4 | Verastem Inc | 2.67% | 411,097 | $3.4M |
| 5 | Precigen Inc | 2.24% | 378,763 | $2.9M |
| 6 | Halozyme Therapeutics Inc | 2.11% | 24,252 | $2.7M |
| 7 | Kiniksa Pharmaceuticals International Plc (KNSA) | 1.99% | 32,483 | $2.5M |
| 8 | Xeris Biopharma Holdings Inc | 1.97% | 248,233 | $2.5M |
| 9 | Zai Lab Ltd | 1.96% | 98,741 | $2.5M |
| 10 | Rigel Pharmaceuticals Inc | 1.93% | 51,309 | $2.5M |
| 11 | BeOne Medicines Ltd | 1.82% | 6,373 | $2.3M |
| 12 | ImmunityBio Inc | 1.82% | 237,394 | $2.3M |
| 13 | Protagonist Therapeutics Inc | 1.70% | 15,354 | $2.2M |
| 14 | Novavax Inc | 1.67% | 189,808 | $2.1M |
| 15 | ADMA Biologics Inc | 1.64% | 205,298 | $2.1M |
| 16 | Regeneron Pharmaceuticals Inc | 1.61% | 2,753 | $2.0M |
| 17 | Tarsus Pharmaceuticals Inc | 1.57% | 27,207 | $2.0M |
| 18 | Kura Oncology Inc | 1.56% | 186,243 | $2.0M |
| 19 | Gilead Sciences Inc | 1.55% | 13,420 | $2.0M |
| 20 | Amgen Inc | 1.54% | 4,745 | $2.0M |
| 21 | Zymeworks Inc | 1.54% | 73,667 | $2.0M |
| 22 | Roivant Sciences Ltd | 1.53% | 56,108 | $1.9M |
| 23 | Ligand Pharmaceuticals Inc | 1.52% | 6,595 | $1.9M |
| 24 | Sarepta Therapeutics Inc | 1.51% | 110,091 | $1.9M |
| 25 | Harmony Biosciences Holdings Inc | 1.51% | 48,911 | $1.9M |
Sector Weights
- Healthcare: 100.00%
Country Weights
- United States: 85.56%
- United Kingdom: 4.87%
- Switzerland: 3.21%
- China: 1.96%
- Denmark: 1.39%
- Germany: 1.39%
- Canada: 1.34%
- Other: 0.28%
Shares, value and weight are as reported in the file, dated by the data source's last update of it (not the date of the positions), never adjusted; a split warning appears only for a split close to or after that date, and its absence does not mean the count is on today's share basis. Weights as the fund reports them. Leveraged and inverse funds list swaps and cash, so weights can be negative or add up past 100.